US open Futures point lower on JJ shock CPI in focus
The mood in the market has turned sour after J&J single shot covid vaccine is paused. CPI data up next.
Share this:
US futures
Dow futures -0.35% at 33630
S&P futures -0.27% at 4117
Nasdaq futures -0.05% at 13814
In Europe
FTSE -0.2% at 6876
Dax +0.03% at 15231
Euro Stoxx -0.03% at 3962
Learn more about trading indices
J&J vaccine paused on blood clot concerns
US stocks are heading lower in risk off trade. The mood in the market turned negative following an announcement from both the FDA and the CDCP that they have recommended the pause in the use of Johnson & Johnson’s vaccine amid concerns over rare blood clots.
This news is a considerable set back for the US’s covid vaccine rollout. As a single shot vaccine, the J&J jab has the potential to speed up the vaccine programme significantly in the US, where all adults were expected to be eligible for a covid vaccine from next week. With the J&J jab now on hold, a deceleration in the programme is expected. This ultimately means that full scale reopening and normalistation of the economy could take longer.
All eyes on inflation data
Investors have been looking cautiously ahead to US CPI data due shortly. Expectations are for an increase of 0.5% MoM and 2.5% increase YoY, up from 1.7% in February.
The data come following PPI inflation figures at the end of last week which saw annual wholesale inflation jump at the largest clip in 9 ½ years. A stronger than forecast number could boost expectations of an earlier move by the Fed to tighten policy, even though the Fed has been clear than any rise in inflation is likely to be temporary
FX – EUR outperforms, GBP has worst week this year
The US Dollar is rising in risk off trade after the J&J covid vaccine announcement.
GBP/USD is under pressure following disappointing GDP data. The UK economy expanded 0.4% in February a firm rebound from January’s -2.2% contraction, but still falling short of the 0.6% expected.
AUD/USD is lagging its peers after disappointing Chinese trade data. China reported a 30.6% rise in exports in March YoY, against expectations of a 35.5% increase. Imports rose by a more than expected 38.1% against a 23.3% annual rise expected. The softer data raised questions over momentum behind the Chinese economic recovery, hitting the Australian Dollar a China proxy.
GBP/USD -0.15% at 1.3722
EUR/USD -0.17% at 1.1888
WTI crude oil pushes above $60.00 may not last
Oil prices are advancing for a second consecutive day clawing back some of last week’s 3.5% loss. Upbeat data from both China, along with tension in the Middle East are supporting oil prices.
Chinese crude oil imports jumped 21% in March, albeit from a low base the year before. The data suggests that refining operations and fuel demand ramped up amid the pandemic recovery.
The pick up in oil prices could be short lived following the J&J announcement. A slower vaccine rollout in the US means a slower recovery.
Attention will now turn to crude oil inventories which are expected to drop again last week, marking the third week of declines. However, gasoline inventories are expected rise as lockdown restrictions tightened in Europe and parts of South America.
US crude trades +0.4% at $60.02
Brent trades +0.6% at $63.44
Learn more about trading oil here.
The complete guide to trading oil markets
Looking ahead
13:30 CPI
13:55 Redbook
21:30 API crude oil inventory
US futures
Dow futures -0.35% at 33630
S&P futures -0.27% at 4117
Nasdaq futures -0.05% at 13814
In Europe
FTSE -0.2% at 6876
Dax +0.03% at 15231
Euro Stoxx -0.03% at 3962
Learn more about trading indices
J&J vaccine use paused sending futures lower
US stocks are heading lower in risk off trade. The mood in the market turned negative following an announcement from both the FDA and the CDCP that they have recommended the pause in the use of Johnson & Johnson’s vaccine amid concerns over rare blood clots.
This news is a considerable set back for the US’s covid vaccine rollout. As a single shot vaccine, the J&J jab has the potential to speed up the vaccine programme significantly in the US, where all adults were expected to be eligible for a covid vaccine from next week. With the J&J jab now on hold, a deceleration in the programme is expected. This ultimately means that full scale reopening and normalistation of the economy could take longer.
All eyes on inflation data
Investors have been looking cautiously ahead to US CPI data due shortly. Expectations are for an increase of 0.5% MoM and 2.5% increase YoY, up from 1.7% in February.
The data come following PPI inflation figures at the end of last week which saw annual wholesale inflation jump at the largest clip in 9 ½ years. A stronger than forecast number could boost expectations of an earlier move by the Fed to tighten policy, even though the Fed has been clear than any rise in inflation is likely to be temporary
FX – EUR outperforms, GBP has worst week this year
The US Dollar is rising in risk off trade after the J&J covid vaccine announcement.
GBP/USD is under pressure following disappointing GDP data. The UK economy expanded 0.4% in February a firm rebound from January’s -2.2% contraction, but still falling short of the 0.6% expected.
AUD/USD is lagging its peers after disappointing Chinese trade data. China reported a 30.6% rise in exports in March YoY, against expectations of a 35.5% increase. Imports rose by a more than expected 38.1% against a 23.3% annual rise expected. The softer data raised questions over momentum behind the Chinese economic recovery, hitting the Australian Dollar a China proxy.
GBP/USD -0.15% at 1.3722
EUR/USD -0.17% at 1.1888
WTI crude oil pushes above $60.00 may not last
Oil prices are advancing for a second consecutive day clawing back some of last week’s 3.5% loss. Upbeat data from both China, along with tension in the Middle East are supporting oil prices.
Chinese crude oil imports jumped 21% in March, albeit from a low base the year before. The data suggests that refining operations and fuel demand ramped up amid the pandemic recovery.
The pick up in oil prices could be short lived following the J&J announcement. A slower vaccine rollout in the US means a slower recovery.
Attention will now turn to crude oil inventories which are expected to drop again last week, marking the third week of declines. However, gasoline inventories are expected rise as lockdown restrictions tightened in Europe and parts of South America.
US crude trades +0.4% at $60.02
Brent trades +0.6% at $63.44
Learn more about trading oil here.
The complete guide to trading oil markets
Looking ahead
13:30 CPI
13:55 Redbook
21:30 API crude oil inventory
Latest market news
The complete CFD trading experience
Award-winning platforms, competitive spreads, low commissions and dedicated support.
We live and breathe the markets and are dedicated to helping traders realise their ambitions as we continue to set the industry bar.
Economic calendar
Web Trader platform
Our sophisticated web-based platform is packed with features.
Related articles
EUR/USD weekly outlook: Oil, inflation and NFP in focus
After coming under significant pressure in recent weeks, the EUR/USD came off its lows to finish the week on a positive note on Friday, albeit with only a mild rebound. That was not enough to prevent the exchange rate falling for the third consecutive week, as the US dollar and bond yields rallied across the board.
EUR/USD Q4 2026 Outlook: Euro at a Crossroads as Fed, ECB Tighten 9 25 2026
EUR/USD enters Q4 at a pivotal inflection point as competing Fed-ECB policy paths and persistent inflation risks collide with major technical support.
S&P 500 Forecast: SPX rises as oil prices fall, but treasuries remain at multi-decade highs
U.S. stocks are rising on Friday after a volatile week that saw a surge in Treasury yields ripple through financial markets.
StoneX Europe Ltd may make third party material available on this website which may contain information included but not limited to the conditions of financial markets. The material is for information purposes only and does not contain, and should not be construed as containing, investment advice and/or investment recommendation and/or an investment research and/or an offer of or solicitation for any transactions in financial instruments; any decision to enter into a specific transaction shall be made by the client following an assessment by him/her of their situation.
StoneX Europe Ltd makes no representation or warranty and assumes no liability as to the accuracy or completeness of the information provided, nor any loss arising from any investment based on a recommendation, forecast or other information supplied. You should always seek independent advice as to your suitability to speculate in any related markets and your ability to assume the associated risks, if you are at all unsure. We are not under any obligation to update any such material. Any opinion made may be personal to the author and may not reflect the opinion of StoneX Europe Ltd.